【摘要】：早產(chǎn)兒呼吸暫停(apnea of prematurity,AOP)是早產(chǎn)兒尤其是極低出生體重兒呼吸管理中較為常見(jiàn)的疾病[1],并且與早產(chǎn)兒出生體重和胎齡有著非常密切的關(guān)系,胎齡、體重越小,AOP發(fā)生的可能性越大,體重小于1000g的早產(chǎn)兒即超低出生體重兒呼吸暫停發(fā)生率高達(dá)80%左右[2]。胎齡在三十周至三十二周的早產(chǎn)兒呼吸暫停發(fā)生率為50%左右。呼吸暫�？梢鹦膭�(dòng)過(guò)緩、低氧血癥,增加腦積水、腦室內(nèi)出血及神經(jīng)系統(tǒng)發(fā)育異常的風(fēng)險(xiǎn)[3],嚴(yán)重時(shí)可能出現(xiàn)死亡。目前國(guó)際上治療AOP的主要藥物是甲基黃嘌呤類藥物,枸櫞酸咖啡因和氨茶堿均屬于黃嘌呤類藥物。有研究表明枸櫞酸咖啡因可以減少低氧血癥時(shí)間及機(jī)械通氣時(shí)間、降低支氣管肺發(fā)育不良(Brochopulmonary dysplasia,BPD)的發(fā)生率。但目前對(duì)有呼吸暫停的患兒肺發(fā)育情況研究不多。早產(chǎn)兒肺功能檢測(cè)是判斷呼吸系統(tǒng)發(fā)育程度[4]、探究呼吸系統(tǒng)疾病及尋找其生長(zhǎng)發(fā)育規(guī)律的十分重要方法[5]。在臨床上可以根據(jù)肺功能檢測(cè)結(jié)果判斷呼吸系統(tǒng)疾病的性質(zhì)、嚴(yán)重程度及監(jiān)控疾病發(fā)展過(guò)程,也可以在治療的過(guò)程中評(píng)估治療效果、協(xié)助選擇呼吸機(jī)的參數(shù)、指導(dǎo)并判斷預(yù)后。常規(guī)的肺功能檢查通常要求受試者非常積極的配合,這大大的阻礙了常規(guī)肺功能檢測(cè)在兒童和新生兒中的應(yīng)用。潮氣呼吸肺功能的檢測(cè)只是需要平靜呼吸,操作相對(duì)簡(jiǎn)單,更加適合不能配合的患者,比如說(shuō)新生兒及年齡小的兒童,所以在臨床上獲得了越來(lái)越多的重視和應(yīng)用。本文通過(guò)枸櫞酸咖啡因?qū)τ蠥OP的極低出生體重兒治療后不同時(shí)期潮氣呼吸肺功能的分析及動(dòng)態(tài)隨訪,以進(jìn)一步探討枸櫞酸咖啡因?qū)ζ浞尾堪l(fā)育所造成的影響。目的通過(guò)對(duì)住院期間有AOP的極低出生體重兒進(jìn)行潮氣呼吸肺功能檢測(cè)及重要肺功能參數(shù)的比較,以探討枸櫞酸咖啡因?qū)O低出生體重兒肺功能的影響。方法1.研究對(duì)象分組本次試驗(yàn)研究對(duì)象為在2015年12月至2016年12月期間在鄭州大學(xué)第三附屬醫(yī)院新生兒病房住院的120例有原發(fā)性呼吸暫停的極低出生體重兒(出生體重1000g~1499g),隨機(jī)根據(jù)數(shù)字法分為氨茶堿應(yīng)用組(P1)和枸櫞酸咖啡因應(yīng)用組(P2),每組各60例。排除標(biāo)準(zhǔn):(1)圍生期有重度窒息史、神經(jīng)系統(tǒng)疾病或功能紊亂;(2)一級(jí)親屬中有哮喘史;(3)母親有吸煙史;(4)存在嚴(yán)重的呼吸窘迫綜合征等呼吸系統(tǒng)疾病;(5)顱內(nèi)出血;(6)敗血癥等感染性疾病;(7)消化系統(tǒng)疾病及電解質(zhì)紊亂;(8)嚴(yán)重的先天性心臟疾病(9)遺傳代謝性疾病;(10)藥物應(yīng)用療程不足者、評(píng)估之前死亡者、放棄治療者;(11)其他因素所引發(fā)的繼發(fā)性呼吸暫停[4]。2.方法本次試驗(yàn)研究選用潮氣呼吸法,在患兒自然睡眠或藥物睡眠(藥物選用10%水合氯醛0.3~0.5m1/kg口服或灌腸)、平靜呼吸狀態(tài)下,將受試者口鼻用面罩扣緊,經(jīng)流速傳感器將流速信號(hào)積分成容量,測(cè)得值可經(jīng)電腦自動(dòng)生成并做好記錄。測(cè)時(shí)前還需要常規(guī)記錄患兒的性別、胎齡,并測(cè)量患兒的身長(zhǎng)和體質(zhì)量,測(cè)定的主要參數(shù)有:潮氣量(Tidal volume,TV)、吸氣時(shí)間(Inspiratory time,TI)、呼氣時(shí)間(Expiratory time,TE)、呼吸頻率(Respiratory rate,RR)、達(dá)峰時(shí)間比(Ratio of TPEF and total tE,TPEF/TE)、達(dá)峰容積比(Ratio of VPEF and totalVE,VPEF/VE)。本試驗(yàn)已經(jīng)獲得我院人體試驗(yàn)委員會(huì)批準(zhǔn)及患兒監(jiān)護(hù)人書面知情同意書。對(duì)研究對(duì)象進(jìn)行第一次潮氣呼吸肺功能檢測(cè)在患兒停用枸櫞酸咖啡因或氨茶堿后(最遲不超過(guò)生后34周)進(jìn)行;并對(duì)兩組患兒隨訪,分別在校正胎齡40周時(shí)和出生后3個(gè)月對(duì)兩組患兒進(jìn)行潮氣呼吸肺功能的檢測(cè),并采用統(tǒng)計(jì)學(xué)方法進(jìn)行分析,研究枸櫞酸咖啡因?qū)O低出生體重兒在不同時(shí)期潮氣呼吸肺功能的影響。結(jié)果1.兩組一般資料比較兩組極低出生體重兒胎齡、出生體重、5minApgar評(píng)分均無(wú)統(tǒng)計(jì)學(xué)差異(P0.05)。2.停藥后(最遲不超過(guò)生后34周)測(cè)定兩組潮氣呼吸肺功能主要參數(shù)的差異試驗(yàn)組即咖啡因組潮氣量、達(dá)峰容積比、達(dá)峰時(shí)間比、25%潮氣量時(shí)呼氣流速均高于對(duì)照組即氨茶堿組,并且與氨茶堿組相比有統(tǒng)計(jì)學(xué)意義(p0.05),余各項(xiàng)潮氣呼吸肺功能指標(biāo)無(wú)明顯統(tǒng)計(jì)學(xué)差異(p0.05)。3.極低出生體重兒在校正胎齡40周時(shí)兩組潮氣呼吸肺功能主要參數(shù)的差異在極低出生體重兒在校正胎齡40周時(shí)試驗(yàn)組即咖啡因組潮氣量、達(dá)峰時(shí)間比及50%潮氣量時(shí)呼氣流速、25%潮氣量時(shí)呼氣流速均高于對(duì)照組即氨茶堿組,其差異有統(tǒng)計(jì)學(xué)意義(p0.05),余各項(xiàng)潮氣呼吸肺功能指標(biāo)無(wú)明顯統(tǒng)計(jì)學(xué)差異(p0.05)。4.出生后3個(gè)月兩組肺功潮氣呼吸肺功能主要參數(shù)的差異極低出生體重兒出生后3個(gè)月時(shí)試驗(yàn)組即咖啡因組潮氣量較對(duì)照組即氨茶堿組高,并且差異有統(tǒng)計(jì)學(xué)意義(p0.05);而達(dá)峰容積比、達(dá)峰時(shí)間比及75%潮氣量時(shí)呼氣流速、50%潮氣量時(shí)呼氣流速、25%潮氣量時(shí)呼氣流速與氨茶堿組相比無(wú)統(tǒng)計(jì)學(xué)意義(p0.05)。結(jié)論枸櫞酸咖啡因治療極低出生體重兒呼吸暫停近遠(yuǎn)期潮氣呼吸肺功能均有明顯改善。
[Abstract]:Premature apnea of prematurity (AOP) is a common disease in respiratory management of premature infants, especially very low birth weight infants [1], and has a very close relationship with the birth weight and gestational age of premature infants. The smaller the gestational age and weight, the greater the possibility of AOP. Premature infants weighing less than 1000g are called very low birth weight infants. The incidence of apnea is as high as 80%[2]. The incidence of apnea is about 50% in preterm infants between 30 and 32 weeks of gestation. Apnea can cause bradycardia, hypoxemia, increase the risk of hydrocephalus, intraventricular hemorrhage and abnormal nervous system development [3], and may lead to death in severe cases. Caffeine citrate and aminophylline are xanthine drugs. Studies have shown that caffeine citrate can reduce the duration of hypoxemia and mechanical ventilation, and reduce the incidence of bronchopulmonary dysplasia (BPD). Premature infants'pulmonary function test is a very important method to judge the degree of respiratory system development, explore the respiratory system diseases and find out their growth and development rules [5].In clinic, according to the results of pulmonary function test, we can judge the nature of respiratory system diseases, severity and monitor the process of disease development, and can also be treated too. Routine pulmonary function tests usually require very active cooperation, which greatly hinders the application of routine pulmonary function tests in children and newborns. More and more attention has been paid to the use of caffeine citrate in the treatment of very low birth weight (VLBW) infants with AOP. In this paper, we analyzed the tidal respiratory and pulmonary function of infants with AOP at different stages after treatment and followed up dynamically. Objective To investigate the effects of caffeine citrate on pulmonary function in very low birth weight infants with AOP during hospitalization by tidal breathing pulmonary function test and comparison of important pulmonary function parameters. Methods 1. Subjects were divided into two groups: subjects from December 2015 to December 2015. 120 very low birth weight infants with primary apnea (birth weight 1000g ~ 1499g) hospitalized in the neonatal ward of the Third Affiliated Hospital of Zhengzhou University in December 2016 were randomly divided into aminophylline application group (P1) and caffeine citrate application group (P2), 60 in each group. Exclusive criteria: (1) severe asphyxia occurred during perinatal period. Nervous system disease or dysfunction; (2) First degree relatives have a history of asthma; (3) mothers have a history of smoking; (4) severe respiratory distress syndrome and other respiratory diseases; (5) intracranial hemorrhage; (6) septicemia and other infectious diseases; (7) digestive system disease and electrolyte disorders; (8) serious congenital heart disease; (9) genetic metabolic diseases; (10) Methods In this study, tidal breathing was used to treat the children with spontaneous sleep or drug sleep (10% chloral hydrate 0.3-0.5m1/kg orally or enema) and the subjects were given oral sedation breathing. The nasal mask is fastened tightly, and the flow signal is integrated into volume by flow sensor. The measured value can be automatically generated and recorded by computer. Expiratory time (TE), Respiratory rate (RR), Ratio of TPEF and total time (TPEF/TE), Ratio of VPEF and total volume (VPEF/VE). This experiment has been approved by the Human Trial Committee of our hospital and written informed consent of the patient's guardian. Pulmonary function test was performed after cessation of caffeine citrate or aminophylline (no later than 34 weeks after birth); and two groups of children were followed up, respectively at the adjusted gestational age of 40 weeks and 3 months after birth, tidal breathing pulmonary function of the two groups of children were tested, and statistical methods were used to analyze the effect of caffeine citrate on very low levels. Results 1. There was no significant difference in gestational age, birth weight and 5-minute Apgar score between the two groups (P 0.05). 2. After stopping medication (no later than 34 weeks after birth) to determine the main parameters of tidal breathing lung function between the two groups: caffeine group Tidal volume, peak volume ratio, peak time ratio, expiratory flow rate at 25% tidal volume were higher than those in the control group, that is, aminophylline group, and there was statistical significance compared with aminophylline group (p0.05). There was no significant difference in the remaining tidal respiratory lung function indicators between the two groups (p0.05). 3. The difference of main parameters was that the tidal volume, peak time ratio, expiratory velocity at 50% tidal volume, and expiratory velocity at 25% tidal volume of very low birth weight infants were higher than those of the control group (aminophylline group) at 40 weeks of corrected gestational age (p0.05). 3 months after birth, the main parameters of pulmonary function were different between the two groups. 3 months after birth, the tidal volume of caffeine group was higher than that of aminophylline group, and the difference was statistically significant (p0.05); and the peak volume ratio, peak time ratio and 75% tidal volume, expiratory velocity, 50% tidal volume Respiratory flow at expiratory volume and at 25% tidal volume were not significantly different from those in aminophylline group (p0.05). Conclusion Caffeine citrate can significantly improve the lung function in very low birth weight infants with apnea.
【學(xué)位授予單位】：鄭州大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R722.6

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 賀湘玲;張兵;田鑫;肖旭平;易紅玲;余闐;;阻塞性睡眠呼吸暫停綜合征患兒手術(shù)前后潮氣呼吸肺功能參數(shù)的變化[J];廣東醫(yī)學(xué);2008年08期

2 易陽(yáng);錢金強(qiáng);鐘聞燕;熊建新;李春華;郭寧;涂國(guó)華;姚圣連;;急性毛細(xì)支氣管炎潮氣呼吸肺功能改變的特征[J];臨床肺科雜志;2009年02期

3 戚虹;;嬰幼兒潮氣呼吸肺功能測(cè)定的影響因素[J];中國(guó)誤診學(xué)雜志;2007年17期

4 林劍;周筱春;張海鄰;蔡曉紅;羅運(yùn)春;;肺炎患兒潮氣呼吸肺功能檢測(cè)及其臨床意義[J];浙江臨床醫(yī)學(xué);2007年08期

5 賀湘玲;田鑫;張兵;肖旭平;易紅玲;;阻塞性睡眠呼吸暫停綜合征患兒潮氣呼吸肺功能變化與多導(dǎo)睡眠監(jiān)測(cè)相關(guān)性研究[J];臨床兒科雜志;2009年03期

6 華子儀;郁志偉;過(guò)靜娟;;體位改變對(duì)喘息嬰幼兒潮氣呼吸肺功能的影響[J];臨床肺科雜志;2009年12期

7 何清順;;兒童潮氣呼吸肺功能指標(biāo)及檢查意義探究[J];實(shí)用預(yù)防醫(yī)學(xué);2009年06期

8 劉靜;季偉;陳正榮;周衛(wèi)芳;儲(chǔ)矗;;甲型H1N1流感肺炎患兒潮氣呼吸肺功能的改變[J];江蘇醫(yī)藥;2011年04期

9 安淑華;李金英;張劍霄;王亞坤;王艷艷;鄭博娟;;潮氣呼吸肺功能測(cè)定在5歲以下支氣管哮喘兒童中的應(yīng)用[J];疑難病雜志;2011年08期

10 王彩姣;;潮氣呼吸肺功能在嬰幼兒呼吸道疾病中的應(yīng)用[J];齊魯護(hù)理雜志;2011年22期

相關(guān)會(huì)議論文 前10條

1 林劍;周筱春;張海鄰;蔡曉紅;羅運(yùn)春;;肺炎患兒潮氣呼吸肺功能檢測(cè)及研究[A];2006（第三屆）江浙滬兒科學(xué)術(shù)會(huì)議暨浙江省兒科學(xué)術(shù)年會(huì)論文匯編[C];2006年

2 李碩;劉傳合;宋欣;趙京;陳育智;;喘息患兒潮氣呼吸肺功能改變的特征[A];中華醫(yī)學(xué)會(huì)第五次全國(guó)哮喘學(xué)術(shù)會(huì)議暨中國(guó)哮喘聯(lián)盟第一次大會(huì)論文匯編[C];2006年

3 賀湘玲;李云;楊于嘉;;嬰幼兒哮喘的潮氣呼吸肺功能變化[A];中華醫(yī)學(xué)會(huì)第十四次全國(guó)兒科學(xué)術(shù)會(huì)議論文匯編[C];2006年

4 陳俊松;沈照波;吳素玲;楊麗娟;;潮氣呼吸肺功能在毛細(xì)支氣管炎患兒中的應(yīng)用[A];中華醫(yī)學(xué)會(huì)第十七次全國(guó)兒科學(xué)術(shù)大會(huì)論文匯編（上冊(cè)）[C];2012年

5 程可萍;楊愛(ài)娟;胡源;朱東波;;晚期早產(chǎn)兒潮氣呼吸肺功能研究[A];2012年江浙滬兒科學(xué)術(shù)年會(huì)暨浙江省醫(yī)學(xué)會(huì)兒科學(xué)分會(huì)學(xué)術(shù)年會(huì)、兒內(nèi)科疾病診治新進(jìn)展國(guó)家級(jí)學(xué)習(xí)班論文匯編[C];2012年

6 郭俊良;朱敏敏;;極低出生體重兒診治體會(huì)[A];第五屆全國(guó)優(yōu)生科學(xué)大會(huì)論文匯編[C];2000年

7 胡素君;;降低極低出生體重兒死亡率的護(hù)理措施探討[A];全國(guó)兒科護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2006年

8 胡素君;;降低極低出生體重兒死亡率的護(hù)理措施探討[A];全國(guó)兒科護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2007年

9 胡素君;;降低極低出生體重兒死亡率的護(hù)理措施探討[A];河南省護(hù)理學(xué)會(huì)產(chǎn)科護(hù)理新進(jìn)展培訓(xùn)班暨兒科護(hù)理風(fēng)險(xiǎn)管理學(xué)術(shù)交流會(huì)議資料匯編[C];2007年

10 葛迎年;童笑梅;陸丹芳;;47例極低出生體重兒臨床分析[A];中華醫(yī)學(xué)會(huì)第十七次全國(guó)兒科學(xué)術(shù)大會(huì)論文匯編（下冊(cè)）[C];2012年

相關(guān)碩士學(xué)位論文 前10條

1 聶暉;潮氣呼吸肺功能測(cè)定在嬰幼兒伴喘息的支氣管肺炎中的應(yīng)用[D];安徽醫(yī)科大學(xué);2016年

2 張麗敏;不同危重程度嬰幼兒重癥肺炎恢復(fù)期潮氣呼吸肺功能的特征[D];鄭州大學(xué);2016年

3 陳佛保;早產(chǎn)兒肺功能檢查的臨床研究[D];廣西醫(yī)科大學(xué);2017年

4 葉侃;兒童潮氣呼吸肺功能研究[D];蘇州大學(xué);2004年

5 張偉;運(yùn)用超聲流量技術(shù)檢測(cè)新生兒潮氣呼吸肺功能的研究[D];遵義醫(yī)學(xué)院;2014年

6 何舒婕;枸櫞酸咖啡因與氨茶堿治療早產(chǎn)兒呼吸暫停的比較[D];北京協(xié)和醫(yī)學(xué)院;2015年

7 王彩紅;枸櫞酸咖啡因?qū)π律笫笕毖跞毖阅X損傷保護(hù)作用的研究[D];鄭州大學(xué);2015年

8 劉洪杰;枸櫞酸咖啡因治療早產(chǎn)兒呼吸暫停的療效及安全性觀察[D];新疆醫(yī)科大學(xué);2016年

9 程慧清;枸櫞酸咖啡因?qū)Ω腥舅滦律笫竽X損傷的保護(hù)作用[D];鄭州大學(xué);2016年

10 黃琴;枸櫞酸咖啡因及氨茶堿在不同呼吸支持狀態(tài)下對(duì)早產(chǎn)兒臨床治療效益：回顧性多中心隊(duì)列研究[D];重慶醫(yī)科大學(xué);2016年

，

本文編號(hào)：2220537